Spots Global Cancer Trial Database for tobacco use disorder
Every month we try and update this database with for tobacco use disorder cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II A Trial of Curcumin Among Patients With Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci) | NCT00365209 | Healthy, no Evi... Tobacco Use Dis... | laboratory biom... pharmacological... curcumin | 40 Years - | National Cancer Institute (NCI) | |
| Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia | NCT00611650 | Lung Cancer Precancerous Co... Tobacco Use Dis... | defined green t... placebo | 45 Years - 74 Years | British Columbia Cancer Agency | |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | NCT00310115 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | Smoking Prevent... Counseling Inte... Counseling Inte... | 18 Years - | M.D. Anderson Cancer Center | |
| Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum | NCT00573885 | Lung Cancer Tobacco Use Dis... | defined green t... placebo | 45 Years - 74 Years | British Columbia Cancer Agency | |
| Screening Methods in Finding Lung Cancer Early in Current or Former Smokers | NCT00751660 | Lung Cancer Tobacco Use Dis... | laboratory biom... screening quest... bronchoscopic a... computed tomogr... endoscopic biop... quality-of-life... | 50 Years - 75 Years | British Columbia Cancer Agency | |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | NCT00790569 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | nicotine varenicline placebo | 18 Years - 120 Years | Butler Hospital | |
| Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer | NCT01457469 | Limited Stage S... Recurrent Small... Stage IA Non-sm... Stage IB Non-sm... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... Stage IIIB Non-... Tobacco Use Dis... | questionnaire a... quality-of-life... counseling inte... internet-based ... telephone-based... educational int... nicotine replac... educational int... | 18 Years - | Wake Forest University Health Sciences | |
| Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years | NCT01344005 | Lung Cancer Tobacco Use Dis... | caregiver-relat... questionnaire a... quality-of-life... radiography | 60 Years - | National Cancer Institute (NCI) | |
| Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules | NCT02169271 | Current Smoker Former Smoker Multiple Pulmon... Tobacco Use Dis... | Aspirin Laboratory Biom... Placebo | 50 Years - | National Cancer Institute (NCI) | |
| Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use | NCT00799669 | Head and Neck C... Tobacco Use Dis... | smoking cessati... counseling inte... preventive inte... questionnaire a... | 18 Years - | M.D. Anderson Cancer Center | |
| p16 Methylation for Smoking Cessation | NCT01038492 | Tobacco Use Dis... Smoking Cessati... Lung Cancer | p16 Methylation... | - | Duke University | |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
| Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers | NCT01021215 | Tobacco Use Dis... | Zileuton Celecoxib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2 | NCT00158145 | Tobacco Use Dis... | 55 Years - 74 Years | National Institute on Drug Abuse (NIDA) | ||
| Tobacco Use Intervention Among Radiation Oncology Patients | NCT00587353 | Tobacco Use Dis... | Behavioral and ... | 18 Years - | Mayo Clinic | |
| Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer | NCT01647425 | Head and Neck C... Lung Cancer | physician asses... | 18 Years - | Centre Oscar Lambret | |
| Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers | NCT00691132 | Lung Cancer Tobacco Use Dis... | phenethyl isoth... placebo | 21 Years - 70 Years | University of Minnesota | |
| Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | NCT00666978 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | smoking cessati... bupropion hydro... gene expression... polymerase chai... counseling inte... educational int... psychosocial as... | 18 Years - | University of Kansas Medical Center | |
| Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1 | NCT00218179 | Tobacco Use Dis... Lung Cancer | Non-interventio... | 55 Years - 74 Years | University of Minnesota | |
| Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers | NCT01021215 | Tobacco Use Dis... | Zileuton Celecoxib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bupropion in Helping Adults Stop Smoking | NCT00534001 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | bupropion hydro... placebo | 18 Years - 65 Years | Roswell Park Cancer Institute | |
| Smoking Tobacco Cessation Integrated Program of Patients Treated for the Head and the Neck Cancer | NCT03788785 | Carcinoma, Squa... Tobacco Use Dis... | Experimental ar... Control arm | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer | NCT00542373 | Erythroplakia Fanconi Anemia Lichen Planus Oral Cavity and... Oral Cavity Leu... Oral Neoplasm Premalignant Le... Tobacco Use Dis... | Cytology Specim... Diagnostic Micr... Diagnostic Proc... Fluorescence Im... Fluorescence Sp... | 18 Years - | M.D. Anderson Cancer Center | |
| Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer | NCT01673711 | Lung Cancer Squamous Lung D... Tobacco Use Dis... | deuterated phen... pharmacological... laboratory biom... | 18 Years - | University of Minnesota | |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | NCT00790569 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | nicotine varenicline placebo | 18 Years - 120 Years | Butler Hospital | |
| Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer | NCT01647425 | Head and Neck C... Lung Cancer | physician asses... | 18 Years - | Centre Oscar Lambret | |
| Bupropion in Helping Adults Stop Smoking | NCT00534001 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | bupropion hydro... placebo | 18 Years - 65 Years | Roswell Park Cancer Institute | |
| Switching to Potential Reduced Exposure Products in Adult Smokers | NCT04250727 | Tobacco Use Dis... Oral Nicotine P... Smoking Behavio... Harm Reduction Toxic Effect of... Carcinogenesis | ZYN | 21 Years - 77 Years | Yale University | |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
| Smoking Cessation CM for Veterans With or at Risk for Cancer | NCT06432985 | Tobacco Use Dis... Substance Use D... | Focus Group Contingency Man... Behavioral Coun... TUD Treatment a... | 18 Years - | VA Office of Research and Development | |
| Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia | NCT00368927 | Precancerous Co... Stage I Non-sma... Tobacco Use Dis... | sulindac placebo | 40 Years - 79 Years | National Cancer Institute (NCI) | |
| Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia | NCT00611650 | Lung Cancer Precancerous Co... Tobacco Use Dis... | defined green t... placebo | 45 Years - 74 Years | British Columbia Cancer Agency | |
| Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients | NCT01434342 | Lung Cancer Tobacco Use Dis... Breast Cancer Colorectal Canc... Prostate Cancer | Nicotine Replac... | 18 Years - | Wake Forest University Health Sciences | |
| Bupropion in Helping Adults Stop Smoking | NCT00534001 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | bupropion hydro... placebo | 18 Years - 65 Years | Roswell Park Cancer Institute | |
| Zinc Supplements in Lowering Cadmium Levels in Smokers | NCT00376987 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | zinc oxide | 21 Years - 120 Years | Wake Forest University Health Sciences | |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
| Electronic Cigarette Use During Pregnancy | NCT03480373 | Cigarette Smoki... | 16 Years - 45 Years | UConn Health | ||
| p16 Methylation for Smoking Cessation | NCT01038492 | Tobacco Use Dis... Smoking Cessati... Lung Cancer | p16 Methylation... | - | Duke University | |
| Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia | NCT00611650 | Lung Cancer Precancerous Co... Tobacco Use Dis... | defined green t... placebo | 45 Years - 74 Years | British Columbia Cancer Agency | |
| Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers | NCT00899262 | Lung Cancer Tobacco Use Dis... | immunohistochem... laboratory biom... sputum cytology Fourier transfo... diagnostic bron... | - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
